Literature DB >> 9202126

A new protein containing an SH2 domain that inhibits JAK kinases.

T A Endo1, M Masuhara, M Yokouchi, R Suzuki, H Sakamoto, K Mitsui, A Matsumoto, S Tanimura, M Ohtsubo, H Misawa, T Miyazaki, N Leonor, T Taniguchi, T Fujita, Y Kanakura, S Komiya, A Yoshimura.   

Abstract

The proliferation and differentiation of cells of many lineages are regulated by secreted proteins known as cytokines. Cytokines exert their biological effect through binding to cell-surface receptors that are associated with one or more members of the JAK family of cytoplasmic tyrosine kinases. Cytokine-induced receptor dimerization leads to the activation of JAKs, rapid tyrosine-phosphorylation of the cytoplasmic domains, and subsequent recruitment of various signalling proteins, including members of the STAT family of transcription factors, to the receptor complex. Using the yeast two-hybrid system, we have now isolated a new SH2-domain-containing protein, JAB, which is a JAK-binding protein that interacts with the Jak2 tyrosine-kinase JH1 domain. JAB is structurally related to CIS, a cytokine-inducible SH2 protein. Interaction of JAB with Jak1, Jak2 or Jak3 markedly reduces their tyrosine-kinase activity and suppresses the tyrosine-phosphorylation and activation of STATs. JAB and CIS appear to function as negative regulators in the JAK signalling pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202126     DOI: 10.1038/43213

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  302 in total

1.  Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis.

Authors:  S F Lee; H M Huang; J R Chao; S Lin; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1.

Authors:  R L Haspel; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 3.  Interleukin-2 signaling and inherited immunodeficiency.

Authors:  N A Cacalano; J A Johnston
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 4.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

5.  Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system.

Authors:  M L Vignais; M Gilman
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 6.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

Authors:  C J Auernhammer; S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Putting the brakes on arthritis: can suppressors of cytokine signaling (SOCS) suppress rheumatoid arthritis?

Authors:  R Rottapel
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

8.  Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization.

Authors:  M Martinez-Moczygemba; D P Huston
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

9.  Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma.

Authors:  L Maródi; K Goda; A Palicz; G Szabó
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

10.  Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

Authors:  Daniela Ungureanu; Pipsa Saharinen; Ilkka Junttila; Douglas J Hilton; Olli Silvennoinen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.